LEADER 01489nam  2200457   450 
001 9910815145703321
005 20230807213417.0
010   $a92-0-118819-6
035   $a(CKB)3710000001364555
035   $a(MiAaPQ)EBC4853263
035   $a(Au-PeEL)EBL4853263
035   $a(CaPaEBR)ebr11384191
035   $a(OCoLC)987091972
035   $a(EXLCZ)993710000001364555
100   $a20170602h20152015  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aRadiopharmaceuticals for sentinel lymph node detection $estatus and trends /$fInternational Atomic Energy Agency
210  1$aVienna, [Austria] :$cInternational Atomic Energy Agency,$d2015.
210  4$dİ2015
215   $a1 online resource (179 pages) $cillustrations (some color)
225 1 $aIAEA Radioisotopes and Radiopharmaceuticals Series,$x2077-6462 ;$vNumber 6
311   $a92-0-109714-X 
410  0$aIAEA radioisotopes and radiopharmaceuticals series ;$vNumber 6.
606   $aRadioactive tracers
606   $aLymph nodes$xBiopsy
606   $aCancer$xDiagnosis
615  0$aRadioactive tracers.
615  0$aLymph nodes$xBiopsy.
615  0$aCancer$xDiagnosis.
676   $a574.191
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910815145703321
996   $aRadiopharmaceuticals for sentinel lymph node detection$93925781
997   $aUNINA